Epidemiology of neurological manifestations in Sjögren's syndrome: Data from the French ASSESS Cohort

RMD Open

Volumn 2, Issue 1, 2016, Pages

  Alegria, Guillermo Carvajal ^a   Guellec, Dewi ^a   Mariette, Xavier ^b   Gottenberg, Jacques Eric ^c   Dernis, Emmanuelle ^d   Dubost, Jean Jacques ^e   Trouvin, Anne Priscille ^f   Hachulla, Eric ^g   Larroche, Claire ^h   Le Guern, Veronique ⁱ   Cornec, Divi ^a   Devauchelle Pensec, Valérie ^a   Saraux, Alain ^a  

^a Universite de Brest   (France)

^b INSERM U1184   (France)

^c HÔPITAL DE HAUTEPIERRE   (France)

^d CENTRE HOSPITALIER DU MANS   (France)

^e SERVICE DE RHUMATOLOGIE   (France)

^f Dept de Médecine Interne Ctr Hosp Univ Rouen Boisguillaume   (France)

^g LILLE UNIVERSITY HOSPITAL   (France)

^h AVICENNE HOSPITAL   (France)

ⁱ Institut Cochin   (France)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84988322156     PISSN: None     EISSN: 20565933     Source Type: Journal    
DOI: 10.1136/rmdopen-2015-000179     Document Type: Article

References (29)

1. Tincani A, Andreoli L, Cavazzana I, et al. Novel aspects of Sjögren's syndrome in 2012. BMC Med 2013;11:93.
2. Cornec D, Saraux A, Cochener B, et al. Level of agreement between 2002 American-European consensus group and 2012 American College of Rheumatology classification criteria for Sjögren's syndrome and reasons for discrepancies. Arthritis Res Ther 2014;16: R74.
3. Alexander E, Provost T, Stevens M, et al. Neurologic complications of primary Sjögren's syndrome. Medicine (Baltimore) 1982;61:247-57.
4. Carvajal Alegria G, Guellec D, Devauchelle-Pensec V, et al. Is there specific neurological disorders of primary Sjögren's syndrome? Joint Bone Spine 2015;82:86-9.
5. Jamilloux Y, Magy L, Hurtevent JF, et al. Immunological profiles determine neurological involvement in Sjögren's syndrome. Eur J Intern Med 2014;25:177-81.
6. Tobon GJ, Pers JO, Devauchelle-Pensec V, et al. Neurological disorders in primary Sjögren's syndrome. Autoimmune Dis 2012;2012:645967.
7. Brito-Zeron P, Akasbi M, Bosch X, et al. Classification and characterisation of peripheral neuropathies in 102 patients with primary Sjögren's syndrome. Clin Exp Rheumatol 2013;31:103-10.
8. Gemignani F, Marbini A, Pavesi G, et al. Peripheral neuropathy associated with primary Sjögren's syndrome. J Neurol Neurosurg Psychiatr 1994;57:983-6.
9. Alexander G, Provost TT, Stevens MB, et al. Sjogren's syndrome: central nervous system manifestations. Neurology 1981;31:1391-6.
10. Morreale M, Marchione P, Giacomini P, et al. Neurological involvement in primary Sjögren's syndrome: a focus on central nervous system. PLoS ONE 2014;9:e84605.
11. Seror R, Ravaud P, Bowman SJ, et al. EULAR Sjogren's syndrome disease activity index: development of a consensus systemic disease activity index for primary Sjogren's syndrome. Ann Rheum Dis 2010;69:1103-9.
12. Seror R, Ravaud P, Mariette X, et al. EULAR Sjogren's Syndrome Patient Reported Index (ESSPRI): development of a consensus patient index for primary Sjogren's syndrome. Ann Rheum Dis 2011;70:968-72.
13. Ramos-Casals M, Brito-Zeron P, Solans R, et al. Systemic involvement in primary Sjögren's syndrome evaluated by the EULAR-SS disease activity index. Rheumatology (Oxford) 2014;53:321-31.
14. Kim SM, Walters P, Vincent A, et al. Sjögren's syndrome myelopathy: spinal cord involvement in Sjögren's syndrome might be a manifestation of neuromyelitis optica. Mult Scler 2009;15:1062-8.
15. Jayarangaiah A, Sehgal R, Epperla N. Sjögren's syndrome and neuromyelitis optica spectrum disorders (NMOSD) - a case report and review of literature. BMC Neurol 2014;14:200.
16. Liu JY, Zhao T, Zhou CK. Central nervous system involvement in primary Sjogren's syndrome manifesting as multiple sclerosis. Neurosciences (Riyadh) 2014;19:134-7.
17. Verma R, Lalla R, Patil TB, et al. Acute myeloneuropathy: an uncommon presentation of Sjögren's syndrome. Ann Indian Acad Neurol 2013;16:696-8.
18. Sharma R, Chilukuri V, Sarma AK, et al. Primary Sjogren's syndrome presenting as acute cerebellitis. J Clin Neurosci 2014;21:508-9.
19. Moreira I, Teixeira F, Martins Silva A, et al. Frequent involvement of central nervous system in primary Sjögren syndrome. Rheumatol Int 2015;35:289-94.
20. Cornec D, Chiche L. Is primary Sjögren's syndrome an orphan disease? A critical appraisal of prevalence studies in Europe. Ann Rheum Dis 2015;74:e25.
21. Massara A, Bonazza S, Castellino G, et al. Central nervous system involvement in Sjögren's syndrome: unusual, but not unremarkable - clinical, serological characteristics and outcomes in a large cohort of Italian patients. Rheumatology (Oxford) 2010;49:1540-9.
22. van Leeuwen N, Bossema ER, Knoop H, et al. Psychological profiles in patients with Sjögren's syndrome related to fatigue: a cluster analysis. Rheumatology (Oxford) 2015;54:776-83.
23. Mengshoel AM, Norheim KB, Omdal R. Primary Sjögren's syndrome: fatigue is an ever-present, fluctuating, and uncontrollable lack of energy. Arthritis Care Res (Hoboken) 2014;66:1227-32.
24. Epstein LC, Masse G, Harmatz JS, et al. Characterization of cognitive dysfunction in Sjögren's syndrome patients. Clin Rheumatol 2014;33:511-21.
25. Blanc F, Longato N, Jung B, et al. Cognitive dysfunction and dementia in primary Sjögren's syndrome. ISRN Neurol 2013;2013:501327.
26. Seror R, Theander E, Brun JG, et al. Validation of EULAR primary Sjögren's syndrome disease activity (ESSDAI) and patient indexes (ESSPRI). Ann Rheum Dis 2015;74:859-66.
27. Seror R, Bowman SJ, Brito-Zeron P, et al. EULAR Sjögren's syndrome disease activity index (ESSDAI): a user guide. RMD Open 2015;1:e000022.
28. Seror R, Bootsma H, Saraux A, et al. Defining disease activity states and clinically meaningful improvement in primary Sjögren's syndrome with EULAR primary Sjögren's syndrome disease activity (ESSDAI) and patient-reported indexes (ESSPRI). Ann Rheum Dis 2016;75:382-9.
29. Brito-Zerón P, Kostov B, Solans R, et al. Systemic activity and mortality in primary Sjögren syndrome: predicting survival using the EULAR-SS disease activity index (ESSDAI) in 1045 patients. Ann Rheum Dis 2016;75:348-55.